Skip to Main Content

Author Details

Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
2005
415
58
PMIDPaper TitleJournal TitlePublished Year
37872280Integrated genotype-phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas.Virchows Arch2024
37558578Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636].Ann Oncol2024
36379463Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.Z Gastroenterol2023
37562657Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.Gastroenterology2023
37525239High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.J Ovarian Res2023
37957250Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer.Sci Rep2023
37657453[Molecular tumor diagnostics as the driving force behind precision oncology].Dtsch Med Wochenschr2023
37894418Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.Cancers (Basel)2023
37792098[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology].Pathologie (Heidelb)2023
37586177Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.Lung Cancer2023
37548948[Testing deficient mismatch repair and microsatellite instability : A focused update. German version].Pathologie (Heidelb)2023
37507610Application of a validated prostate MRI deep learning system to independent same-vendor multi-institutional data: demonstration of transferability.Eur Radiol2023
37544709Tumour mutational burden and survival with molecularly matched therapy.Eur J Cancer2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37874379Testing for deficient mismatch repair and microsatellite instability : A focused update.Pathologie (Heidelb)2023
37641393Precision cancer medicine: Concepts, current practice, and future developments.J Intern Med2023
37639843Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.Eur J Radiol2023
37391339Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study.Clin Lung Cancer2023
37059713Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis.Cell Death Discov2023
37058788Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations.Lung Cancer2023
37058257DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.Clin Cancer Res2023
37455247Implementation of precision medicine in healthcare-A European perspective.J Intern Med2023
37280276The German Network for Personalized Medicine to enhance patient care and translational research.Nat Med2023
37141769Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.Lung Cancer2023
37371836An Uncommon Cause of Recurrent Presyncope, Dizziness, and Tachycardia: A Case Report of Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS).Biomedicines2023
37371827Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia.Biomedicines2023
37238245Detection Rate of Prostate Cancer in Repeat Biopsy after an Initial Negative Magnetic Resonance Imaging/Ultrasound-Guided Biopsy.Diagnostics (Basel)2023
37205635The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization.Cancer Res2023
37068173Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.Cancer Discov2023
37331287Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.Eur J Radiol2023
36961477Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.Oncologist2023
37327584Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).Transl Oncol2023
37260092Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study.Eur J Endocrinol2023
36445224Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners.Genes Chromosomes Cancer2023
36852573Real-world data for precision cancer medicine-A European perspective.Genes Chromosomes Cancer2023
36808802Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.Mol Oncol2023
36436002Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination.Clin Res Cardiol2023
36738930Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC.J Thorac Oncol2023
36608320A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.Blood2023
36932239[The biomarker PIK3CA in tumor pathology].Pathologie (Heidelb)2023
36735063Structure and content of the EU-IVDR : Current status and implications for pathology.Pathologie (Heidelb)2023
36635225First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.J Pathol Clin Res2023
36562826BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.Cancer Immunol Immunother2023
36726983Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.Front Immunol2023
36372281Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol2023
36170665FGFR2 Inhibition in Cholangiocarcinoma.Annu Rev Med2023
34331337Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.Genes Chromosomes Cancer2022
35384413Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.J Pathol Clin Res2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
  • 1 - 50 of 415

Recommended Authors

Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 16
Nanjing Geneseeq Technology Inc.
Career Start Year 2012
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 2
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 29
University of Bern
Career Start Year 2009
Number of shared co-authors 13
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 2
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 4
University of Basel
Career Start Year 2008
Number of shared co-authors 9
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 5
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 17
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 1
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 5
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 5
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 29
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 10
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 33
University of California
Career Start Year 2003
Number of shared co-authors 3
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 10
Monash University
Career Start Year 2000
Number of shared co-authors 5
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 15
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 9
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 14
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 13
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 16
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 19

Collaborators

Institute of Pathology, University Hospital Heidelberg
Co-authored papers 126
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 100
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 72
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 70
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 60
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 59
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 55
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 54
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 37
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 35
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 34
German Cancer Research Center (DKFZ)
Co-authored papers 31
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 24
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 23
German Cancer Research Center (DKFZ)
Co-authored papers 23
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 19
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 18
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Co-authored papers 16
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 15
University of Augsburg
Co-authored papers 13
Pathologisches Institut, Universitatsklinikum Heidelberg
Co-authored papers 12
Co-authored papers 11
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 11
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 10
Berlin Institute of Health (BIH) and Charite
Co-authored papers 10
Institute of Pathology, Charite Universitatsmedizin Berlin
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 8
Co-authored papers 8
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 8